Rash from EGFR inhibitors: Opportunities and challenges for palliation
Rash from EGFR inhibitors: Opportunities and challenges for palliation
复制标题
EGFR 抑制剂引起的皮疹：姑息治疗的机遇和挑战
DOI：
10.1007/s11912-008-0048-1
复制
发表时间：
2008
影响因子：
4.7
通讯作者：
A. Jatoi
中科院分区：
文献类型：
--
作者：
B. Solomon;A. Jatoi
The epidermal growth factor receptor (EGFR) inhibitors represent a relatively new class of cancer agents that also provide new challenging side effects for cancer patients. This article reviews the clinical aspects of EGFR inhibitor-induced rash, which occurs most commonly with use of these agents, and discusses some of the challenges faced in attempting palliation treatment.
大麻素抑制大鼠肝上皮细胞系中间隙连接细胞间通讯并激活 ERK。
影响因子：
6.4
作者：
Upham,BradL;Rummel,AlisaM;Carbone,JosephM;Trosko,JamesE;Ouyang,Yanli;Crawford,RobertB;Kaminski,NorbertE
通讯作者：
Kaminski,NorbertE